Our mission is to support our patients with mental or neurological disorders from the initial diagnostic to the end of the intervention, offering them state of the art technology to evaluate and treat ...
Entropy Neurodynamics Limited, a clinical-stage pharmaceutical development company, focuses on developing formulations for the administration of psilocin in combination with psychotherapy to treat ...
Trailing total returns as of 12/23/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) Return TYPTF S&P/ASX 200 [XJO] (^AXJO) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback